ENT & Allergy Deal Activity Cools Off to Begin 2022 Look For Additional PE Investor Interest Ahead

The first quarter of 2022 delivered two reported ENT practice acquisitions, coming down from a flurry of deal activity to end last year.


Andy Snyder, a FOCUS Managing Director, has ten years of consulting, management, and M&A advisory experience among various healthcare positions. He has significant experience advising physicians in medical practice and surgery center transactions – including the specialties of ophthalmology, gastroenterology, dermatology, and orthopedics. His current practice includes healthcare provider services, home health and hospice, and behavioral health.